Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 24/03/25

Trade details

Type
Insider sale
Amount
$2,046,330.5
Shares · price
8,650 sh · $236.57 a share
Held after
2,627 sh
Trade date
24/03/21
Filed
24/03/25
Days to filing
4 days

Sold 76.7% of holdings

Share of holding sold
76.7%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/20~24/04/20

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Planned sale10b5-1 planUnited Therapeutics

    $113.3M

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $2M of United Therapeutics UTHR · 76.7% of holdings · 10b5-1 plan | Whalegun